![Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide structure, CAS 2004659-83-8](/structures/210000/181193_2_2004659_83_8.png)
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 2004659-83-8 |
| Catalog No. | 2A-3180359 |
| Chinese Name | Unii-Q3WJ23B6JD |
| Molecular Formula | C20H19N5O3 |
| Molecular Weight | 377.4 |
| PubChem ID | 434048097 |
| SMILES | CNC(=O)c1cc(Nc2ccc(Oc3ccnc(C(=O)NC)c3)cc2)ccn1 |
| InChI | InChI=1S/C20H19N5O3/c1-21-19(26)17-11-14(7-9-23-17)25-13-3-5-15(6-4-13)28-16-8-10-24-18(12-16)20(27)22-2/h3-12H,1-2H3,(H,21,26)(H,22,27)(H,23,25) |
| InChI Key | KPCKULBSMTYWPY-UHFFFAOYSA-N |
| Related Products in Analytical Standards | ||
|---|---|---|
| Ledipasvir impurity 8 | 2040487-27-0 | 2A-3180332 |
| Linagliptin Impurity H | 1646355-34-1 | 2A-3180346 |
| Pantoprazole Impurity 11 | 172282-50-7 | 2A-3180350 |
| Sorafenib impurity 14/Isopropyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate | 2206827-14-5 | 2A-3180354 |
| Sorafenib impurity 16/Ethyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate | 2206827-12-3 | 2A-3180355 |
| Tadalafil EP Impurity | 479545-76-1 | 2A-3180379 |
| Nintedanib impurity I | 334951-61-0 | 2A-3180392 |
| Nintedanib impurity I | 894783-61-0 | 2A-3180393 |
| Nintedanib impurity YZ | 1139455-52-9 | 2A-3180394 |
| Nintedanib impurity E | 262366-32-5 | 2A-3180395 |
| Browse all Analytical Standards products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA